Is nivolumab an option for Hodgkin's lymphoma?

Gisselbrecht, Christian

Is nivolumab an option for Hodgkin's lymphoma? [electronic resource] - The Lancet. Oncology 09 2016 - 1183-4 p. digital

Publication Type: Journal Article; Comment

1474-5488

10.1016/S1470-2045(16)30220-0 doi


Antibodies, Monoclonal
Hodgkin Disease
Humans
Nivolumab